1-4 of 4
Junfang Chen
Close
Sort by
Journal Articles

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Clinical Trials & Observations
Stefan O. Ciurea, Mei-Jie Zhang, Andrea A. Bacigalupo, Asad Bashey, Frederick R. Appelbaum, Omar S. Aljitawi, Philippe Armand, Joseph H. Antin, Junfang Chen, Steven M. Devine, Daniel H. Fowler, Leo Luznik, Ryotaro Nakamura, Paul V. O’Donnell, Miguel-Angel Perales, Sai Ravi Pingali, David L. Porter, Marcie R. Riches, Olle T. H. Ringdén, Vanderson Rocha, Ravi Vij, Daniel J. Weisdorf, Richard E. Champlin, Mary M. Horowitz, Ephraim J. Fuchs, Mary Eapen
Journal: Blood
Blood (2015) 126 (8): 1033–1040.
https://doi.org/10.1182/blood-2015-04-639831
Published: 2015
Includes: Supplemental data
Journal Articles

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Mei-Jie Zhang, PhD, Andrea Bacigalupo, MD, Asad Bashey, MD PhD, Frederick R. Appelbaum, MD, Joseph H. Antin, MD, Junfang Chen, MS, Steven M. Devine, MD, Daniel H. Fowler, MD, Ryotaro Nakamura, MD, Miguel-Angel Perales, MD, Sai Ravi Pingali, MD, David L. Porter, MD, Olle Ringdén, MDPhD, Vanderson Rocha, MD PhD, Ravi Vij, MD, Daniel J. Weisdorf, MD, Richard E. Champlin, Ephraim J. Fuchs, Mary Eapen, MBBS
Journal: Blood
Blood (2014) 124 (21): 679.
https://doi.org/10.1182/blood.V124.21.679.679
Published: 2014
Journal Articles

Comparable 3-Year Disease-Free Survival Regardless of Anti-Thymocyte Globulin Inclusion in Pediatric Myeloablative Cord Blood Transplantation for Acute Lymphoblastic Leukemia

Doris M. Ponce, MD, Rodney Sparapani, PhD, Junfang Chen, MS, Vanderson Rocha, MD PhD, Daniel H. Fowler, MD, Mary Eapen, MBBS, Juliet N. Barker, MBBS(Hons), FRACP, Miguel-Angel Perales, MD
Journal: Blood
Blood (2014) 124 (21): 1259.
https://doi.org/10.1182/blood.V124.21.1259.1259
Published: 2014
Journal Articles

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Thörlén, MD, Olle Ringdén, MD, PhD, Jennifer Le Rademacher, PhD, Minoo Battiwalla, MD, MS, Junfang Chen, MS, Vincent T. Ho, MD, Partow Kebriaei, MD, Carolyn A. Keever-Taylor, PhD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Michael Lill, MD, BS, Tracey A. O’Brien, FRACP, MBChB, MHL, BSc, Miguel Angel Perales, MD, Vanderson Rocha, MD, PhD, Bipin N. Savani, MD, David Szwajcer, MD, FRCPC, David Valcarcel, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2013) 122 (21): 3342.
https://doi.org/10.1182/blood.V122.21.3342.3342
Published: 2013